vs
Side-by-side financial comparison of Amber International Holding Ltd (AMBR) and bioAffinity Technologies, Inc. (BIAF). Click either name above to swap in a different company.
Amber International Holding Ltd is the larger business by last-quarter revenue ($1.9M vs $1.6M, roughly 1.2× bioAffinity Technologies, Inc.). Amber International Holding Ltd runs the higher net margin — 87.5% vs -197.0%, a 284.5% gap on every dollar of revenue.
Amber International Holding LtdAMBREarnings & Financial Report
Amber Road, Inc. (NYSE: AMBR) was a US-based software company specializing in Global Trade Management (GTM) solutions. It was acquired by E2open in 2019.
bioAffinity Technologies, Inc. is a clinical-stage biotechnology firm focused on developing non-invasive in vitro diagnostic tests for early detection of cancer and respiratory diseases. It serves global healthcare markets, with a core mission to deliver accessible, high-accuracy diagnostic solutions that improve patient outcomes and reduce overall healthcare system costs.
AMBR vs BIAF — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.9M | $1.6M |
| Net Profit | $1.6M | $-3.1M |
| Gross Margin | 39.9% | — |
| Operating Margin | 1.5% | -196.9% |
| Net Margin | 87.5% | -197.0% |
| Revenue YoY | — | -27.8% |
| Net Profit YoY | — | -5.7% |
| EPS (diluted) | $0.02 | $-3.59 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $1.6M | ||
| Q3 25 | — | $1.4M | ||
| Q2 25 | $1.9M | $1.3M | ||
| Q1 25 | — | $1.9M | ||
| Q4 24 | — | $2.2M | ||
| Q3 24 | — | $2.4M | ||
| Q2 24 | — | $2.4M | ||
| Q1 24 | — | $2.4M |
| Q4 25 | — | $-3.1M | ||
| Q3 25 | — | $-5.1M | ||
| Q2 25 | $1.6M | $-4.1M | ||
| Q1 25 | — | $-2.7M | ||
| Q4 24 | — | $-3.0M | ||
| Q3 24 | — | $-2.0M | ||
| Q2 24 | — | $-2.1M | ||
| Q1 24 | — | $-2.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 39.9% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | -196.9% | ||
| Q3 25 | — | -158.6% | ||
| Q2 25 | 1.5% | -198.2% | ||
| Q1 25 | — | -141.7% | ||
| Q4 24 | — | -133.5% | ||
| Q3 24 | — | -84.0% | ||
| Q2 24 | — | -87.1% | ||
| Q1 24 | — | -80.8% |
| Q4 25 | — | -197.0% | ||
| Q3 25 | — | -349.3% | ||
| Q2 25 | 87.5% | -319.9% | ||
| Q1 25 | — | -143.5% | ||
| Q4 24 | — | -134.4% | ||
| Q3 24 | — | -85.1% | ||
| Q2 24 | — | -88.0% | ||
| Q1 24 | — | -81.5% |
| Q4 25 | — | $-3.59 | ||
| Q3 25 | — | $-4.74 | ||
| Q2 25 | $0.02 | $-0.17 | ||
| Q1 25 | — | $-0.16 | ||
| Q4 24 | — | $-17.27 | ||
| Q3 24 | — | $-4.84 | ||
| Q2 24 | — | $-0.19 | ||
| Q1 24 | — | $-0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $25.8M | $6.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $91.3M | $7.3M |
| Total Assets | $248.2M | $11.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $6.4M | ||
| Q3 25 | — | $7.7M | ||
| Q2 25 | $25.8M | $802.8K | ||
| Q1 25 | — | $444.7K | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | — | $756.6K | ||
| Q2 24 | — | $801.3K | ||
| Q1 24 | — | $2.5M |
| Q4 25 | — | $7.3M | ||
| Q3 25 | — | $8.9M | ||
| Q2 25 | $91.3M | $-2.1M | ||
| Q1 25 | — | $1.4M | ||
| Q4 24 | — | $2.6M | ||
| Q3 24 | — | $3.1M | ||
| Q2 24 | — | $3.4M | ||
| Q1 24 | — | $5.3M |
| Q4 25 | — | $11.0M | ||
| Q3 25 | — | $11.5M | ||
| Q2 25 | $248.2M | $4.8M | ||
| Q1 25 | — | $5.5M | ||
| Q4 24 | — | $6.5M | ||
| Q3 24 | — | $6.6M | ||
| Q2 24 | — | $6.7M | ||
| Q1 24 | — | $8.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-4.1M | $-2.6M |
| Free Cash FlowOCF − Capex | — | $-2.6M |
| FCF MarginFCF / Revenue | — | -160.7% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | -2.49× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-9.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-2.6M | ||
| Q3 25 | — | $-2.5M | ||
| Q2 25 | $-4.1M | $-2.6M | ||
| Q1 25 | — | $-1.6M | ||
| Q4 24 | — | $-1.7M | ||
| Q3 24 | — | $-1.7M | ||
| Q2 24 | — | $-1.5M | ||
| Q1 24 | — | $-2.3M |
| Q4 25 | — | $-2.6M | ||
| Q3 25 | — | $-2.5M | ||
| Q2 25 | — | $-2.7M | ||
| Q1 25 | — | $-1.7M | ||
| Q4 24 | — | $-1.7M | ||
| Q3 24 | — | $-1.7M | ||
| Q2 24 | — | $-1.6M | ||
| Q1 24 | — | $-2.4M |
| Q4 25 | — | -160.7% | ||
| Q3 25 | — | -171.8% | ||
| Q2 25 | — | -209.6% | ||
| Q1 25 | — | -91.3% | ||
| Q4 24 | — | -76.0% | ||
| Q3 24 | — | -73.1% | ||
| Q2 24 | — | -65.1% | ||
| Q1 24 | — | -99.2% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 1.1% | ||
| Q1 25 | — | 2.7% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | 1.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -2.49× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
